Pfizer's Xeljanz cleared for ulcerative colitis in Europe

1st August 2018 Uncategorised 0

Drug becomes the first oral therapy and Janus kinase (JAK) inhibitor available for UC

More: Pfizer's Xeljanz cleared for ulcerative colitis in Europe
Source: News